I couldn't possibly answer that ...
Whatever bio/pharmo can come up with a 100% effective treatment for HCV ... particularly if it's a stand alone from interferon/ribavirin will be a licence to print money ... IMO
I have already said this ... the current treatment supplied by Roche is on the PBS and costs around 44k per patient ... gives you some idea